drugset / Trial / NCT06344325

ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia

NCT06344325

Phase 4 Completed 330 enrolled Tongji Hospital
Non-randomizedParallel-groupTriple-blindTreatment

Summary

Exploring the 90% effective dose (ED90) of fospropofol disodium in induction and maintenance of anesthesia in adults of different ages, providing more clinical evidence for the application of fospropofol disodium in clinical anesthesia

Timeline

Start
2024-05-01
Primary completion
2025-02-28
Completion
2025-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject fospropofol Small molecule 7.5 mg/kg
Subject fospropofol Small molecule 10 mg/kg
Subject fospropofol Small molecule 15 mg/kg

Indications

No indication recorded.